If depression has not improved enough with antidepressants or traditional therapy, there may still be options. iMind offers advanced, evidence-based treatment pathways designed for people living with difficult-to-treat depression.
Tell us what kind of support you are looking for. The iMind team can help match you with an appropriate provider and verify your benefits.
Living with persistent depression can be exhausting, especially after trying medication or therapy without the improvement you hoped for. Treatment-resistant depression does not mean that you are out of options.
At iMind Mental Health Solutions, clinicians evaluate your symptoms, treatment history, health needs, and goals to determine whether an advanced treatment such as TMS or Spravato® may be appropriate.
Your plan should be based on your clinical needs—not a one-size-fits-all protocol. iMind can help determine which treatment path may be appropriate after a clinical evaluation.
Transcranial Magnetic Stimulation uses targeted magnetic pulses to stimulate areas of the brain involved in mood. It is non-invasive, does not require anesthesia, and patients can typically return to normal activities after treatment.
Spravato® is an FDA-approved esketamine nasal spray administered in a certified clinical setting with monitoring. It may be considered for eligible adults with treatment-resistant depression.
Your provider reviews past treatments, current symptoms, medical history, and goals to build a plan that may include advanced treatment, medication management, therapy, or a combination of services.
Tell the team what you have been experiencing and which treatments you have already tried.
The team can review insurance coverage and explain relevant authorization requirements.
A qualified provider determines whether TMS, Spravato®, or another treatment approach is clinically appropriate.
If eligible, treatment is scheduled with ongoing clinical supervision and progress monitoring.
Advanced depression treatment may be worth discussing if your symptoms are significantly affecting your daily life or if previous treatments have not provided enough relief.
iMind provides TMS and Spravato® alongside therapy and psychiatric care, allowing treatment planning to consider more than one approach.
The team can verify benefits and help you understand coverage before treatment begins.
iMind serves patients through its Treasure Coast locations with licensed mental health and psychiatric professionals.
“When I was introduced to TMS, I was skeptical yet intrigued… I’m truly grateful I took the suggestion and started TMS.”
— iMind TMS patient testimonial, excerpted for mockup
The term is commonly used when depression has not improved adequately after appropriate treatment attempts. A clinician can review your treatment history and determine whether that description fits your situation.
Spravato® is the brand name for an FDA-approved esketamine nasal spray. It is administered under supervision in a certified treatment setting.
TMS is a non-invasive brain stimulation treatment that uses magnetic pulses to target areas involved in mood regulation. It does not require anesthesia and typically has no recovery downtime.
Coverage depends on your plan, diagnosis, prior treatment history, and authorization requirements. iMind can verify your benefits before treatment.
Treatment availability can vary by service and location. Contact iMind to confirm the nearest location for the treatment you need.
145 NW Central Park Plaza, Suite 200 Port St. Lucie, FL 34986
10 SE Central Parkway, Suite 100 Stuart, FL 34994
705 17th Street Vero Beach, FL 32960
Talk with iMind about treatment-resistant depression, TMS, and Spravato®.
Email: info@imindmental.com
Phone: (772) 257-4523